Moderna says updated COVID shot boosts omicron protection


PTI, Jun 9, 2022, 9:36 AM IST

Washington DC: Moderna’s experimental COVID-19 vaccine that combines its original shot with protection against the omicron variant appears to work, the company announced on Wednesday.

COVID-19 vaccine makers are studying updated boosters that might be offered in the fall to better protect people against future coronavirus surges.

Moderna’s preliminary study results show people given the combination shot experienced an eight-fold increase in virus-fighting antibodies capable of targeting the omicron mutant, the company announced.

Today’s COVID-19 vaccines all are based on the original version of the coronavirus. They’re still providing strong protection against severe disease, hospitalisation and death even after the appearance of the super-contagious omicron variant — especially if people have had a booster dose.

But the virus continues to mutate rapidly in ways that let it evade some of the vaccines’ protections and cause milder infections.

So US regulators, and the World Health Organisation, are considering whether to order a change in the vaccine recipe for a new round of booster shots in the fall — when cold weather and kids returning to school are expected to drive yet another surge.

Key questions: How to make that change without losing the continued strong protection against COVID-19’s worst outcomes? And what’s the right variant to target? After the huge winter omicron surge, that mutant’s genetically distinct siblings now are the main threats, including one that’s fuelling the current US wave of infections.

The Food and Drug Administration has set a meeting in late June for its scientific advisers to debate those questions and evaluate data from vaccine makers’ tests of potential new formulas. Pfizer also is studying a combination shot, what scientists call a bivalent vaccine.

Moderna said its new study found that a month after the combo shot, recipients harboured higher omicron-fighting antibody levels — and cross-protection against other prior variants — than the original vaccine triggers.

However, antibodies naturally wane so it’s not clear how long the protection against infection will last.

The study was performed in 437 people, and safety was similar to today’s boosters, Moderna said. The results were announced in a press release and haven’t undergone scientific review.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’

Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial

100 engineering colleges in Karnataka to be ‘adopted’ by corporates by next year: IT Minister Kharge

Siddaramaiah defends BPL ration card cancellation, says only ineligible beneficiaries affected

China announces new policy measures to protect its exports from Trump’s new tariff threat

Renovated Medical Oncology OPD and Chemotherapy Day Care Centre inaugurated at Kasturba Hospital, Manipal

Karnataka Health Minister justifies revision of user fees in state-run hospitals

Related Articles More

World COPD Day: Know your lung function

As Delhi chokes with dangerous pollution levels, doctors warn of health risks for all

World Diabetes Day 2024: Kasturba Hospital Manipal Hosts Zumba Session at Malpe Beach to Raise Diabetes Awareness

World Diabetes Day: An overview of types of diabetes

World Diabetes Day: One-fourth of people living with diabetes in 2022 are in India, Lancet study estimates

MUST WATCH

Christmas Cake Fruit Mixing

DK Shivakumar

Rose Cultivation

Geethotsava

Naxal Operation


Latest Additions

Siddaramaiah says confident of winning all three bypolls in Karnataka

Hop on! IT Minister Priyank Kharge checks out Uber Shuttle at Bengaluru Tech Summit

Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’

Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial

AIMPLB to hold its annual general sessions in Bengaluru from November 23

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.